We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Diastolic Dysfunction in Sickle Cell Disease During Vaso-occlusive Crisis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2012 by Abdulsalam Alaithan, King Abdulaziz Medical City.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01683968
First Posted: September 12, 2012
Last Update Posted: September 13, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
King Abdulaziz Medical City
Information provided by (Responsible Party):
Abdulsalam Alaithan, King Abdulaziz Medical City
  Purpose

This study is designed to investigate the presence and absence of abnormal heart muscle contractions during sickle cell crises.

You will be asked to do echocardiography during and after your admission to the hospital. We will compare tow pictures and study the differences.


Condition
Sickle Cell

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Diastolic Dysfunction in Sickle Cell Disease During Vaso-occlusive Crisis

Resource links provided by NLM:


Further study details as provided by Abdulsalam Alaithan, King Abdulaziz Medical City:

Estimated Enrollment: 216
Study Start Date: September 2012
Estimated Study Completion Date: October 2015
Estimated Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
Sickle cell
Patient who are admitted with sickle cell crises

  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   14 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adult patient admitted to the hospital with vaso-occlusive crisis
Criteria

Inclusion criteria:

  1. Patients older than 18 years
  2. Diagnosis of acute vaso-occlusive crisis due to sickle cell disease.
  3. Informed consent

Exclusion criteria:

  1. Congenital heart disease
  2. Long standing hypertension
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01683968


Contacts
Contact: Dr Abdulsalam M Alaithan, MD 96635910000 ext 33445 aithana@ngha.med.sa

Locations
Saudi Arabia
King Abdulaziz Hospital Recruiting
Al-Ahsa, EP, Saudi Arabia, 31982
Contact: Abdulsalam MA Alaithan, MD    96635910000 ext 33445    aithana@ngha.med.sa   
Sponsors and Collaborators
King Abdullah International Medical Research Center
King Abdulaziz Medical City
  More Information

Responsible Party: Abdulsalam Alaithan, CONSULTANT INTENSIVEST AND PULMONOLOGIST, King Abdulaziz Medical City
ClinicalTrials.gov Identifier: NCT01683968     History of Changes
Other Study ID Numbers: RE11/027
First Submitted: September 8, 2012
First Posted: September 12, 2012
Last Update Posted: September 13, 2012
Last Verified: September 2012

Additional relevant MeSH terms:
Anemia, Sickle Cell
Anemia, Hemolytic, Congenital
Anemia, Hemolytic
Anemia
Hematologic Diseases
Hemoglobinopathies
Genetic Diseases, Inborn


To Top